ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies
Author:
Funder
Natural Science Foundation of Shandong Province
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference98 articles.
1. Non-Invasive assessment of hypoxia and neovascularization with MRI for identification of aggressive breast cancer;Bennani-Baiti;Cancers,2020
2. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes;Neve;Cancer Cell,2006
3. Epigenetic mechanisms in breast cancer therapy and resistance;Garcia-Martinez;Nat. Commun.,2021
4. Inhibition of APE1 expression enhances the antitumor activity of olaparib in triple-negative breast cancer;Jian;Evid. -Based Complement. Altern. Med.: eCAM,2022
5. miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2;Wang;Oncol. Res.,2021
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis;The Journal of Gene Medicine;2024-02
2. Gold Nanoparticles Downregulate IL-6 Expression/Production by Upregulating microRNA-26a-5p and Deactivating the RelA and NF-κBp50 Transcription Pathways in Activated Breast Cancer Cells;International Journal of Molecular Sciences;2024-01-24
3. LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway;Taiwanese Journal of Obstetrics and Gynecology;2024-01
4. Construction and analysis of pseudogene-related ceRNA network in breast cancer;Scientific Reports;2023-12-10
5. Circ_0002395 promotes aerobic glycolysis and proliferation in pancreatic adenocarcinoma cells via miR-548c-3p/PDK1 axis;Journal of Bioenergetics and Biomembranes;2023-12-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3